Moreover, it is significant to acknowledge that patients with CKD commonly experience lowered erythropoietin levels and exhibit heightened levels of prolactin, which ultimately leads to an increased incidence of anemia and decreased levels of hemoglobin. Here, EPO is linked to anemia (phenotype).